Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“MedCity news is a peerless national resource for those of us who really want to stay on top the very latest news in healthcare from incumbents to startups. ”

Elliot Menschik, DreamIt Ventures partner; Venturef0rth founder; Penn professor


Sign up for our daily newsletter


After $3B federal settlement, GSK pressured to settle Avandia patient suits

12:50 pm by | 1 Comments

A week after GlaxoSmithKline (NYSE:GSK) reached a $3 billion federal settlement over claims it illegally marketed Avandia and other drugs, the drugmaker now faces pressure to resolve the thousands of Avandia patient lawsuits that remain.

Judge Cynthia Rufe, U.S. district judge for the Eastern District of Pennsylvania, appointed a mediator to oversee settlement negotiations for Avandia cases before the Philadelphia judge, Bloomberg News reports. Rufe set a 75-day deadline to resolve 85 percent of the unspecified number of remaining cases.

Rufe’s order appoints Lafayette, Louisiana lawyer Patrick Juneau to mediate the cases. Juneau’s firm claims he has mediated more than 2,000 cases, including product liability litigation over heartburn drug Propulsid that involved thousands of claimants throughout the country.

Advertisement

British pharmaceutical company GlaxoSmithKline has its U.S. headquarters in Research Triangle Park, North Carolina. Cases concerning diabetes drug Avandia stretch back over the last decade. The former blockbuster drug came under its heaviest scrutiny last year as concerns about cardiovascular risks linked to the drug mounted in the United States and abroad. U.S. and European regulators last year slapped heavy restrictions on Avandia that all but barred the product from the market.

The $3 billion federal settlement is expected to cover civil and criminal liabilities arising from the federal probes. Bloomberg reports that GSK earlier this year agreed to more than $700 million in patient settlements that resolved more than 10,000 cases. But an untold number of patients’ lawsuits are still unresolved.

“GSK welcomes the court’s mediation order and looks forward to constructive discussions with the special master,” GSK spokeswoman Bernadette King told Bloomberg.

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

By Frank Vinluan

Frank Vinluan is the North Carolina Bureau Chief for MedCity News.
More posts by Author

1 comments
sallybruns
sallybruns

Many people have died from Avandia and the 46,000 - minus 41% of what the attorneys get isn't enough for these people to pay for their medical bills and operations. Damn!! They could have at least given them enough to buy a house and a decent car with all the damage they have done. Avandia may well be dissing out pennies and in settlements and have payed off the powers that be, but they will oneday have to face their Maker and give an account for all the deaths, heart attacks, strokes, CHFs, kidney failures, damaged bodies that remain, and all the lies they've told!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Hear the latest news first

Get our daily newsletter or follow us.

 

Advertisement